Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Contineum Therapeutics, Inc. (CTNM) Insider Trading

1 open-market trades reported since Sep 8, 2026: 0 purchases worth $0 and 1 sales worth $41K.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Carmine N. StengoneCEO0$01$41KSep 8, 2026

All trades

CTNM insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 8Sep 8Carmine N. StengoneCEOCEO▼ SELL10b5-12,50016.46$41K−13%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings